Filed: 2/13/2026ACC: 0002106181-26-000003
📋 What this filing means
KALEHUA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $101.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$101.10M
Total AUM (reported)
14.45M
Total Shares
Allocation by class
COM$43.48M43.0%
ALPHA ARCH 1-3$26.56M26.3%
COM NEW$21.12M20.9%
SPONSORED ADS$5.66M5.6%
CLASS A ORD$2.32M2.3%
COM SHS$1.96M1.9%
Portfolio Concentration
Top 3$49.56M49.0%
4–10$34.89M34.5%
11–25$16.65M16.5%
Top 3 weight
49.0%
Top 10 weight
83.5%
Voting Authority Distribution
Total shares with voting rights: 14.45M
Sole
Full voting authority
14.45M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
Alpha Architect 1-3 Month Box Etf
SOLEShares230.79K
TypeSH
Market value$26.56M
26.27%
Sole
230.79K
Shared
0.00
None
0.00
X4 Pharmaceuticals Inc
SOLEShares3.72M
TypeSH
Market value$14.89M
14.73%
Sole
3.72M
Shared
0.00
None
0.00
Sionna Therapeutics Inc
SOLEShares197.07K
TypeSH
Market value$8.11M
8.02%
Sole
197.07K
Shared
0.00
None
0.00
Relay Therapeutics Inc
SOLEShares901.46K
TypeSH
Market value$7.63M
7.54%
Sole
901.46K
Shared
0.00
None
0.00
Compass Pathways Plc
SOLEShares819.69K
TypeSH
Market value$5.66M
5.59%
Sole
819.69K
Shared
0.00
None
0.00
Pharvaris NV
SOLEShares198.77K
TypeSH
Market value$5.52M
5.46%
Sole
198.77K
Shared
0.00
None
0.00
Septerna Inc
SOLEShares194.54K
TypeSH
Market value$5.42M
5.36%
Sole
194.54K
Shared
0.00
None
0.00
Oruka Therapeutics Inc
SOLEShares118.52K
TypeSH
Market value$3.59M
3.55%
Sole
118.52K
Shared
0.00
None
0.00
Inhibikase Therapeutics Inc
SOLEShares1.75M
TypeSH
Market value$3.59M
3.55%
Sole
1.75M
Shared
0.00
None
0.00
Allogene Therapeutics Inc
SOLEShares2.55M
TypeSH
Market value$3.49M
3.45%
Sole
2.55M
Shared
0.00
None
0.00
LeonaBio Inc
SOLEShares393.70K
TypeSH
Market value$2.98M
2.95%
Sole
393.70K
Shared
0.00
None
0.00
MoonLake Immunotherapeutics
SOLEShares175.73K
TypeSH
Market value$2.32M
2.29%
Sole
175.73K
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares267.06K
TypeSH
Market value$2.18M
2.16%
Sole
267.06K
Shared
0.00
None
0.00
Verrica Pharmaceuticals Inc
SOLEShares235.78K
TypeSH
Market value$1.96M
1.94%
Sole
235.78K
Shared
0.00
None
0.00
Tyra Biosciences Inc
SOLEShares74.47K
TypeSH
Market value$1.96M
1.94%
Sole
74.47K
Shared
0.00
None
0.00
Surrozen Inc
SOLEShares385.18K
TypeSH
Market value$1.89M
1.87%
Sole
385.18K
Shared
0.00
None
0.00
Tenaya Therapeutics Inc
SOLEShares2M
TypeSH
Market value$1.42M
1.41%
Sole
2M
Shared
0.00
None
0.00
Kalaris Therapeutics Inc
SOLEShares139.90K
TypeSH
Market value$1.18M
1.17%
Sole
139.90K
Shared
0.00
None
0.00
Diamedica Therapeutics Inc
SOLEShares95.36K
TypeSH
Market value$759.1K
0.75%
Sole
95.36K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alpha Architect 1-3 Month Box EtfSOLE | ALPHA ARCH 1-3 | 230.79K | SH | $26.56M 26.27% | 230.79K | 0.00 | 0.00 |
X4 Pharmaceuticals IncSOLE | COM NEW | 3.72M | SH | $14.89M 14.73% | 3.72M | 0.00 | 0.00 |
Sionna Therapeutics IncSOLE | COM | 197.07K | SH | $8.11M 8.02% | 197.07K | 0.00 | 0.00 |
Relay Therapeutics IncSOLE | COM | 901.46K | SH | $7.63M 7.54% | 901.46K | 0.00 | 0.00 |
Compass Pathways PlcSOLE | SPONSORED ADS | 819.69K | SH | $5.66M 5.59% | 819.69K | 0.00 | 0.00 |
Pharvaris NVSOLE | COM | 198.77K | SH | $5.52M 5.46% | 198.77K | 0.00 | 0.00 |
Septerna IncSOLE | COM | 194.54K | SH | $5.42M 5.36% | 194.54K | 0.00 | 0.00 |
Oruka Therapeutics IncSOLE | COM | 118.52K | SH | $3.59M 3.55% | 118.52K | 0.00 | 0.00 |
Inhibikase Therapeutics IncSOLE | COM NEW | 1.75M | SH | $3.59M 3.55% | 1.75M | 0.00 | 0.00 |
Allogene Therapeutics IncSOLE | COM | 2.55M | SH | $3.49M 3.45% | 2.55M | 0.00 | 0.00 |
LeonaBio IncSOLE | COM | 393.70K | SH | $2.98M 2.95% | 393.70K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | CLASS A ORD | 175.73K | SH | $2.32M 2.29% | 175.73K | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | COM | 267.06K | SH | $2.18M 2.16% | 267.06K | 0.00 | 0.00 |
Verrica Pharmaceuticals IncSOLE | COM SHS | 235.78K | SH | $1.96M 1.94% | 235.78K | 0.00 | 0.00 |
Tyra Biosciences IncSOLE | COM | 74.47K | SH | $1.96M 1.94% | 74.47K | 0.00 | 0.00 |
Surrozen IncSOLE | COM NEW | 385.18K | SH | $1.89M 1.87% | 385.18K | 0.00 | 0.00 |
Tenaya Therapeutics IncSOLE | COM | 2M | SH | $1.42M 1.41% | 2M | 0.00 | 0.00 |
Kalaris Therapeutics IncSOLE | COM | 139.90K | SH | $1.18M 1.17% | 139.90K | 0.00 | 0.00 |
Diamedica Therapeutics IncSOLE | COM NEW | 95.36K | SH | $759.1K 0.75% | 95.36K | 0.00 | 0.00 |